Jitsubo Overview

  • Founded

  • 2005

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 15

Employees
  • Latest Deal Type

  • M&A

Jitsubo General Information

Description

Developer of peptide generic products intended to contribute to the well-being of society through innovative peptide therapeutics. The company offers services related to peptide pharmaceuticals, contract manufacturing of peptide APIs and licensing regarding active ingredient manufacturing technology for peptides, enabling the patient to get peptide pharmaceuticals at a low and affordable cost.

Contact Information

Website
www.jitsubo.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Parent Company
Iwaki
Primary Office
  • 4-1 Life Science Research Center, 1-1-43 Suehiro-cho
  • Tsurumi-ku, Yokohama-shi
  • Kanagawa, 230-0045
  • Japan
+81 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jitsubo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 30-Apr-2021 Completed Generating Revenue
2. Later Stage VC 11-Nov-2016 Completed Generating Revenue
1. Merger/Acquisition 26-Dec-2014 $3.61M 00.000 Completed Generating Revenue
To view Jitsubo’s complete valuation and funding history, request access »

Jitsubo Patents

  • 63

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 9

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Jitsubo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3778621-A1 Peptide synthesis method Pending 13-Apr-2018 00000000
EP-3778621-A4 Peptide synthesis method Pending 13-Apr-2018 00000000 0
JP-6703668-B2 Peptide synthesis method Active 13-Apr-2018 000000000
JP-WO2019198833-A1 Peptide synthesis method Active 13-Apr-2018 000000000 0
US-11420997-B2 Peptide synthesis method Active 13-Apr-2018 C07K1/02 00
To view Jitsubo’s complete patent history, request access »

Jitsubo Executive Team (7)

Name Title Board Seat Contact Info
Hideya Mizufune Ph.D Chief Executive Officer
Kiichiro Ohya Executive Vice President & CSO
Kazuhiro Chiba Ph.D Founder
Kazuaki Kanai Ph.D Chairman
You’re viewing 4 of 7 executive team members. Get the full list »

Jitsubo Board Members (5)

Name Representing Role Since
Kazuaki Kanai Ph.D Jitsubo Chairman 000 0000
You’re viewing 1 of 5 board members. Get the full list »

Jitsubo Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jitsubo Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sosei Corporation Majority 000 0000 000000 0
Universal Materials Incubator Venture Capital Minority 000 0000 000000 0
World Innovation Lab Venture Capital Minority 000 0000 000000 0
To view Jitsubo’s complete investors history, request access »

Ready to get started?

Request a free trial